more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$6.45 USD

+0.05 (0.78%)

Updated Oct 8, 2024 04:00 PM ET

After-Market: $6.44 -0.01 (-0.16%) 6:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5 5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

Bottom 39% (153 out of 252)

Industry: Cosmetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Philip Morris' (PM) IQOS Gets FDA Nod to be Marketed as MRTP

by Zacks Equity Research Published on July 09,2020

Philip Morris (PM) is likely to benefit from the FDA's latest move. Notably, the FDA authorizes IQOS's marketing as a modified risk tobacco product.

consumer-staples

Moving Average Crossover Alert: Nu Skin Enterprises

by Zacks Equity Research Published on July 06,2020

Nu Skin Enterprises, Inc. (NUS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

NUSPositive Net Change

consumer-staples

Will Nu Skin Continue to Surge Higher?

by Zacks Equity Research Published on July 03,2020

As of late, it has definitely been a great time to be an investor of Nu Skin Enterprises

NUSPositive Net Change

consumer-discretionary

Nu Skin (NUS) Revises Q2 Sales View Upward, Stock Rises

by Zacks Equity Research Published on July 02,2020

Nu Skin (NUS) witnesses robust consumer growth during second-quarter 2020. The company raises sales guidance for the quarter.

consumer-staples

Inter Parfums' IPSA Buys Stake in Owner of Origines-parfums

by Zacks Equity Research Published on July 02,2020

Inter Parfums' (IPAR) majorly owned subsidiary ??? Interparfums SA or IPSA ??? pens a deal to buy 25% stake in Divabox. Divabox is the owner of Origines-parfums.

consumer-staples

Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business

by Zacks Equity Research Published on June 30,2020

Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.

consumer-staples

3 Factors That Make Helen of Troy (HELE) an Attractive Pick

by Zacks Equity Research Published on June 24,2020

Strength in Helen of Troy's (HELE) Leadership Brands is driving growth. Moreover, the company's focus on enhancing online business is yielding.

consumer-staples

Tap Market Potential With These 4 Consumer Staples Stocks

by Rajani Lohia Published on June 24,2020

Consumer staples sector shows resilience amid the pandemic due to strong demand for food and other essentials. Efforts to keep pace with consumer trends should bolster the sector's growth.

consumer-staples

Kimberly-Clark (KMB) Looks Scrumptious on Cost-Saving Efforts

by Zacks Equity Research Published on June 22,2020

Kimberly-Clark (KMB) is witnessing higher consumer demand owing to coronavirus induced stockpiling. Also, robust cost-saving efforts bode well.

consumer-staples

Estee Lauder Benefits From Online Sales Amid Store Closures

by Zacks Equity Research Published on June 18,2020

Estee Lauder (EL) is gaining from solid online sales amid coronavirus-led store closures. Also, the company's efficient cost-saving efforts are yielding.

consumer-staples

The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises

by Zacks Equity Research Published on June 18,2020

The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises

consumer-staples

Why Nu Skin (NUS) Could Be a Top Value Stock Pick

by Zacks Equity Research Published on June 18,2020

Nu Skin (NUS) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

NUSPositive Net Change

consumer-staples

5 Consumer Staple Dividend Stocks to Enrich Your Portfolio

by Vrishali Bagree Published on June 17,2020

At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.

consumer-staples

Kraft Heinz Pricing & Efficiency Building Efforts Bode Well

by Zacks Equity Research Published on June 15,2020

Kraft Heinz (KHC) is benefitting from its robust pricing and product-development efforts. Also, the company's enterprise transformation strategies bode well.

consumer-staples

Mondelez's Pricing Strategies Bodes Well, Input Costs a Woe

by Zacks Equity Research Published on June 12,2020

Mondelez (MDLZ) is benefiting from efficient pricing and impressive savings plan. However, higher costs and unfavorable currency rates are troubling.

consumer-staples

Here's Why Helen of Troy (HELE) is Up More Than 35% in a Year

by Zacks Equity Research Published on June 11,2020

Helen of Troy's (HELE) focus on Leadership Brands, sturdy digital efforts and Transformation Plan bode well. It is seeing strong demand in the Health & Home unit thanks to the COVID-19 pandemic.

consumer-staples

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research Published on June 05,2020

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NUSPositive Net Change

Here's Why Nu Skin (NUS) Stock is Up More Than 40% in a Month

by Zacks Equity Research Published on June 04,2020

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.

consumer-staples

Coty (COTY) in Focus: Stock Moves 5.4% Higher

by Zacks Equity Research Published on May 28,2020

Coty (COTY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

consumer-staples

Nu Skin Enterprises' Shares March Higher, Can It Continue?

by Zacks Equity Research Published on May 26,2020

As of late, it has definitely been a great time to be an investor in Nu Skin Enterprises

NUSPositive Net Change

consumer-discretionary

NUS vs. PORBF: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on May 20,2020

NUS vs. PORBF: Which Stock Is the Better Value Option?

Inter Parfums (IPAR) Q1 Earnings Top Estimates, Sales Drop Y/Y

by Zacks Equity Research Published on May 12,2020

Inter Parfums' (IPAR) first-quarter 2020 results reflect coronavirus-led hurdles. The Middle East and Asia were most affected.

Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes

by Vrishali Bagree Published on May 11,2020

The Cosmetics space appears to be under pressure, thanks to coronavirus-led concerns like major travel restrictions, delay in product launches and temporary store closures in some regions.

consumer-staples

Nu Skin's (NUS) Q1 Earnings Beat Estimates, Decline Y/Y

by Zacks Equity Research Published on May 07,2020

Nu Skin's (NUS) first-quarter 2020 results reflect lower earnings and sales. Foreign currency headwinds and reduced sales leaders in Mainland China hurt results.